These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1970775)

  • 41. N-Hydroxylation enzymes of carcinogenic aminoazo dyes: possible involvement of cytochrome P-448.
    Kimura T; Kodama M; Nagata C
    Gan; 1982 Feb; 73(1):55-62. PubMed ID: 6811357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
    Mori Y; Niwa T; Toyoshi K
    Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450.
    Zbaida S; Stoddart AM; Levine WG
    Chem Biol Interact; 1989; 69(1):61-71. PubMed ID: 2914330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of single and concurrent clofibrate and phenobarbital administration on cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation in male rat liver.
    Close I; Shackleton G; Goldfarb PS; Gibson GG; Sharma R; Howes D
    J Biochem Toxicol; 1992; 7(3):193-8. PubMed ID: 1479597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro induction of bilirubin conjugation in primary rat hepatocyte culture.
    Jemnitz K; Lengyel G; Vereczkey L
    Biochem Biophys Res Commun; 2002 Feb; 291(1):29-33. PubMed ID: 11829457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
    MacDonald RS; Swan PB
    Biochim Biophys Acta; 1986 Feb; 880(2-3):153-60. PubMed ID: 3942787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
    Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
    Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of gonadectomy and sex hormones on the induction of hepatic CYP4A by clofibrate in rats.
    Hiratsuka M; Matsuura T; Sato M; Suzuki Y
    Biol Pharm Bull; 1996 Jan; 19(1):34-8. PubMed ID: 8820907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term maintenance of hepatocytes in primary culture in the presence of DMSO: further characterization and effect of nafenopin, a peroxisome proliferator.
    Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
    Exp Cell Res; 1987 Jul; 171(1):37-51. PubMed ID: 3622636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unscheduled DNA synthesis induced by 4-aminoazobenzene, N-hydroxy-4-aminoazobenzene, and their derivatives in primary cultures of rat and mouse hepatocytes.
    Watanabe HK; Hashimoto Y
    Gan; 1981 Dec; 72(6):930-6. PubMed ID: 7341341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between azo reduction and formation in vitro of DNA-bound DAB metabolites in liver microsomes from rats fed on carcinogenic or normal diets.
    Castagna M; Lazar P
    Chem Biol Interact; 1974 Jan; 8(1):61-4. PubMed ID: 4154809
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction of peroxisomal fatty acyl-CoA oxidase and microsomal laurate hydroxylase activities by beclobric acid and two metabolites in primary cultures of rat hepatocytes.
    Kocarek TA; Feller DR
    Biochem Pharmacol; 1987 Sep; 36(18):3027-32. PubMed ID: 3632723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation.
    Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
    Experientia; 1988 Oct; 44(10):823-7. PubMed ID: 3053229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the ingestion of p-dimethylaminoazobenzene (DAB) and 3' methyl-DAB on the capacities of activation of DAB and azoreduction of liver microsomes in the rat].
    Decloitre F; Meunier M; Auffret M
    C R Acad Hebd Seances Acad Sci D; 1972 Jan; 274(5):776-9. PubMed ID: 4622418
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytosolic factors that alter the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes.
    Levine WG; Lee SB
    Biochem Pharmacol; 1983 Nov; 32(21):3137-44. PubMed ID: 6416256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulfuric acid esters as major ultimate electrophilic and hepatocarcinogenic metabolites of 4-aminoazobenzene and its N-methyl derivatives in infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
    Delclos KB; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1986 Feb; 7(2):277-87. PubMed ID: 2419005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses.
    Facino RM; Carini M
    Pharmacol Res Commun; 1981 Oct; 13(9):861-71. PubMed ID: 7335763
    [No Abstract]   [Full Text] [Related]  

  • 58. The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I).
    Ashby J; Lefevre PA; Callander RD
    Mutat Res; 1983 Mar; 116(3-4):271-9. PubMed ID: 6403852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A correlation of the rate of N-hydroxylation of aminoazo dyes with their carcinogenic activity in the rat.
    Kimura T; Kodama M; Nagata C
    Carcinogenesis; 1982; 3(12):1393-6. PubMed ID: 6817940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
    Zbaida S; Brewer CF; Levine WG
    Drug Metab Dispos; 1994; 22(3):412-8. PubMed ID: 8070318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.